OICR’s Molecular Oncology Core Research Resources (MOCRR) were formed in 2004 with the vision of becoming a world leader in molecular oncology analyses, offering a wide range of cutting-edge, comprehensive molecular oncology clinical and research services.
Our Core facilities operate individually and in coordinated sequence supported by OICR’s Adaptive Oncology administration:
- Ontario Tumour Bank (OTB)
- Ontario Health Study (OHS)
- Diagnostic Development Program
- Genomics Program
MOCRR’s Vision
To improve cancer outcomes through molecular oncology.
MOCRR’s Mission
To provide leading-edge, high-quality molecular oncology services that catalyze discovery and innovations, and translate molecular oncology techniques and findings from the laboratory to real-world clinical use. By creating novel services that are unique in Canada and globally, MOCRR supports both basic and clinical research, with the ultimate goal to enable improved health outcomes for all cancer patients through molecular oncology.
Operations Advisory Committee (OAC)
- Brent Zanke
- Michelle Helm
- Patient partner
Core Management Team
- Michelle Brazas (OICR, AO – Chair)
- Carolyn Ptak
- Bernard Lam
- Morgan Taschuk
- Ilinca Lungu
- Sarah Barker
- Dianne Chadwick
- Kelly McDonald
Core Directors
- Dianne Chadwick, Associate Director, Ontario Tumour Bank
- Philip Awadalla, Director, Ontario Health Study
- Jane Bayani, co-Director, Diagnostic Development
- Melanie Spears, co-Director, Diagnostic Development
- Trevor Pugh, Director, Genomics